Hemophagocytosis during fludarabine-based SCT for systemic juvenile idiopathic arthritis.
Ferreira
R A
RA
Vastert
S J
SJ
Abinun
M
M
Foster
H E
HE
Modesto
C
C
Olivé
T
T
Kuis
W
W
Wulffraat
N M
NM
D000293:Adolescent; D001171:Arthritis, Juvenile / Q000628:therapy*; D002648:Child; D005260:Female; D006801:Humans; D008262:Macrophage Activation / Q000276:immunology; D008297:Male; D019653:Myeloablative Agonists / Q000009:adverse effects; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D013577:Syndrome; D019172:Transplantation Conditioning / Q000009:adverse effects* / Q000379:methods; D014182:Transplantation, Autologous; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives
D019653:Myeloablative Agonists; D014740:Vidarabine; C024352:fludarabine